CLINICAL_TRIALS
trial_result
· 2022-05-16
Clinical Trial Update: Evaluation of AZR-MD-001 in Patients With Meibomian Gland Dysfunction (MGD) [Phase 2]
Summary
Phase 2 clinical trial evaluating AZR-MD-001 in Meibomian Gland Dysfunction has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Azura Ophthalmics | Conditions: Meibomian Gland Dysfunction | Phase 2 | Status: COMPLETED | Results posted: 2022-05-16